The three main stock market indexes in the country, the S&P 500, Dow Jones Industrial Average, and Nasdaq, primarily include large-cap companies. However, there are also other indexes composed of small-cap companies, such as the S&P 600 and the Russell 2000.
The Russell 2000 holds particular significance because small companies within it often provide a more accurate reflection of the country's economic health.
These businesses focus on internal and domestic operations, primarily within the US.
To be included in the Russell 2000, companies must meet three requirements:
Small market capitalization companies, commonly referred to as small caps, fall within the $300 million to $2 billion market cap range.
Those above $2 billion are considered medium caps, and the largest are known as large caps or big caps.
Investors interested in small-cap stocks can choose from various specialized vehicles, including mutual funds and ETFs.
But in this piece, we will take a look at five stocks within the Russell 2000 that are highly rated by the market, and we will utilize InvestingPro as our primary source of information.
Karyopharm Therapeutics (NASDAQ:KPTI) is a pharmaceutical company that develops and markets drugs aimed at treating cancer and other diseases.
The company was incorporated in 2008 and is headquartered in Newton, Massachusetts.
It reports quarterly results on February 15. Looking ahead to 2024 the forecast is for earnings per share (EPS) to increase +6.6%, with the increase being +19.3% by 2025.
Source: InvestingPro
Its shares closed the week at $1.04. The potential the market gives it is tremendous, at no less than around $6.
Source: InvestingPro
Rallybio (NASDAQ:RLYB) is a biotech company that is dedicated to
Read more on investing.com